BARBI, Stefano
 Distribuzione geografica
Continente #
NA - Nord America 3.831
EU - Europa 3.560
AS - Asia 2.250
SA - Sud America 238
AF - Africa 67
Continente sconosciuto - Info sul continente non disponibili 60
OC - Oceania 9
Totale 10.015
Nazione #
US - Stati Uniti d'America 3.736
RU - Federazione Russa 1.245
GB - Regno Unito 797
SG - Singapore 788
CN - Cina 755
IT - Italia 481
DE - Germania 217
VN - Vietnam 194
BR - Brasile 191
HK - Hong Kong 187
SE - Svezia 172
FR - Francia 147
FI - Finlandia 139
IE - Irlanda 129
KR - Corea 59
NL - Olanda 59
CA - Canada 54
BD - Bangladesh 53
UA - Ucraina 48
IN - India 39
ES - Italia 31
JP - Giappone 28
BE - Belgio 27
TR - Turchia 27
NG - Nigeria 20
IQ - Iraq 17
MX - Messico 17
ID - Indonesia 16
AR - Argentina 14
AT - Austria 13
ZA - Sudafrica 12
PL - Polonia 11
SA - Arabia Saudita 11
IR - Iran 10
AU - Australia 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
EC - Ecuador 8
CR - Costa Rica 7
CZ - Repubblica Ceca 7
LT - Lituania 6
MA - Marocco 6
TG - Togo 6
CH - Svizzera 5
KG - Kirghizistan 5
AZ - Azerbaigian 4
BJ - Benin 4
BY - Bielorussia 4
CO - Colombia 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
PY - Paraguay 4
TN - Tunisia 4
VE - Venezuela 4
EG - Egitto 3
KZ - Kazakistan 3
NI - Nicaragua 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
GR - Grecia 2
HN - Honduras 2
KE - Kenya 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
NO - Norvegia 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AG - Antigua e Barbuda 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CM - Camerun 1
CV - Capo Verde 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
MD - Moldavia 1
MT - Malta 1
Totale 9.950
Città #
Southend 687
Moscow 451
Singapore 432
Ashburn 412
Chandler 378
Dallas 371
San Jose 326
Jacksonville 262
Hong Kong 180
Ann Arbor 169
Woodbridge 141
Beijing 140
Dublin 129
Verona 124
Council Bluffs 119
Houston 104
New York 98
The Dalles 79
Munich 78
Los Angeles 64
Ho Chi Minh City 58
Shenyang 57
Nanjing 52
Jinan 48
Hanoi 47
Helsinki 47
Lawrence 43
Princeton 43
Wilmington 41
Hebei 35
Tianjin 33
Santa Clara 32
Buffalo 29
Brussels 27
Milan 27
Orem 27
Rome 27
Tokyo 26
Turku 25
São Paulo 24
Changsha 22
Denver 22
Ningbo 22
Frankfurt am Main 21
Guangzhou 21
London 21
Abuja 20
Nanchang 19
Madrid 18
Phoenix 17
Toronto 17
Atlanta 16
Columbus 16
Zhengzhou 16
Amsterdam 15
Chicago 15
Sindelfingen 15
Haikou 14
Brooklyn 13
Jiaxing 13
Redondo Beach 13
Taiyuan 13
Boardman 12
Seattle 12
Stockholm 12
Fairfield 11
Montreal 11
Poplar 11
Taizhou 11
Warsaw 11
Bologna 10
Chennai 10
Dearborn 10
Hangzhou 10
Redmond 10
San Francisco 10
Ankara 9
Falkenstein 9
Johannesburg 9
Mexico City 8
Paris 8
Boston 7
City of London 7
Dong Ket 7
Fuzhou 7
Jakarta 7
Kyiv 7
Mumbai 7
Norwalk 7
Nuremberg 7
Seoul 7
Tashkent 7
Baghdad 6
Bolzano 6
Cleveland 6
Haiphong 6
Hải Dương 6
Kent 6
Las Vegas 6
Lomé 6
Totale 6.190
Nome #
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 388
MAP Kinase inhibition reshapes tumour microenvironment of mouse pancreatic cancer by depleting anti-inflammatory macrophages 311
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 297
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 295
Whole-genome landscape of pancreatic neuroendocrine tumours 294
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene terapy 237
Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis 236
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics 234
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 232
Anti-viral state segregates two molecular phenotypes of pancreatic adenocarcinoma: Potential relevance for adenoviral gene therapy 229
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models 224
MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases 219
Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. 215
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 215
Chromosome 3p alterations in pancreatic endocrine neoplasia 211
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 206
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns 203
Reporting tumor molecular heterogeneity in histopathological diagnosis 203
Loss of Fhit expression is associated with poorer survival in gastric cancer but is not an independent prognostic marker 200
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 199
Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group 198
Divergent mutational processes distinguish hypoxic and normoxic tumours 196
Author Correction: The landscape of viral associations in human cancers 195
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 192
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 191
The analysis of PIK3CA mutations in gastric carcinoma and metanalysis of literature suggest that exon-selectivity is a signature of cancer type 188
Molecular biology of neuroendocrine tumors 188
Microsatellite instability in gastric cancer is associated with better prognosis only in stage II cancers 186
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 184
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 182
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 181
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 178
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 178
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 176
An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen 175
Pancreatic endocrine tumors: expression profiling evidences a role for Akt-mTOR pathway 174
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphoma 173
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 170
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 165
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 162
Wnt (canonical and non canonical) pathways in breast carcinoma with extensive vascular invasion and inflammatory breast carcinoma 159
Low expression of ARHI is associated with shorter progression-free survival in pancreatic endocrine tumors 154
Author Correction: Pan-cancer analysis of whole genomes 151
Landscape of Druggable Molecular Pathways Downstream of Genomic CDH1/Cadherin-1 Alterations in Gastric Cancer 143
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 142
Integrative pathway enrichment analysis of multivariate omics data 137
Mutational profiling of kinases in human tumours of pancreatic origin identifies candidate cancer genes in ductal and ampulla of vater carcinomas 132
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing 128
Whole-exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1 127
Mutazionidi PI3KCA nel cancro gastrico 125
Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig 95
Molecular Biology of Neuroendocrine Tumors 26
Author Correction: The evolutionary history of 2,658 cancers (Nature, (2020), 578, 7793, (122-128), 10.1038/s41586-019-1907-7) 9
Patterns of somatic structural variation in human cancer genomes 7
Totale 10.015
Categoria #
all - tutte 30.963
article - articoli 24.692
book - libri 0
conference - conferenze 4.630
curatela - curatele 0
other - altro 940
patent - brevetti 0
selected - selezionate 0
volume - volumi 701
Totale 61.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022221 0 0 0 35 17 8 4 19 17 6 32 83
2022/2023911 64 120 86 145 82 220 8 58 100 2 13 13
2023/2024486 16 30 39 39 58 86 4 46 21 45 82 20
2024/20251.369 52 69 76 211 73 73 68 47 202 81 149 268
2025/20264.000 243 174 365 670 1.051 274 348 165 316 232 59 103
2026/2027492 41 110 166 175 0 0 0 0 0 0 0 0
Totale 10.015